GeneralConnection.com ➔ Dictionary
Dictionary Search

phase i

Synonyms

Noun

1. phase I clinical trial

2. phase I, clinical trial, clinical test

Usage
Chickasaw Heritage Center Phase I nears completion - Northeast Mississippi Daily Journal
Dodgers’ Shohei Ohtani leads All-Star voting after Phase I, guaranteed a spot in lineup - Orange County Register
Ascletis receives FDA clearance for Phase I trial of obesity treatment - Clinical Trials Arena
Operation Trailblazer Launches to Restore U.S. Leadership to Clinical Trials - Spencer Fane
Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity - PR Newswire
Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 months - Fierce Biotech
Three Phase 3 trials in hard-to-treat cancers initiated - Boehringer Ingelheim
VKTX Stock Jumps on Phase I Study Initiation for New Obesity Drug - Yahoo Finance
Partnership Completes Phase I of Boston Mixed-Use Development - REBusinessOnline
Phase 1 clinical trials, explained: 11 things to know - UT MD Anderson
Preorder Star Wars: The Vintage Collection Phase I Clone Troopers 4-Pack Now - Jedi News
Clearmind finishes 24-patient AUD trial stage; next phase awaits data review - Stock Titan
HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib - GlobeNewswire
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics - Insilico Medicine
Two-Thirds of South Village Still Lacking Landmark Protections, and Endangered - Village Preservation
64 A Phase I/II Study of Pembrolizumab and Anti-CD3 x Anti-HER2 Armed Activated T-Cells in Metastatic Breast Cancer - CancerNetwork
Kither Biotech concludes Phase I study of KIT2014 - Clinical Trials Arena
Vascarta Announces Phase I Results of VAS-101 Administered Sublingually in Sickle Cell Disease Patients - PR Newswire
Viking Therapeutics commences Phase I trial of VK3019 - Yahoo
ABSI Soars 36% on Positive Interim Update From Phase I Hair Loss Study - Yahoo Finance
Stone and Speedway Phase I Awarded $2.5M in Housing Tax Credits - City of Tucson (.gov)
Anodyne Nanotech Raises $12.6M to Advance Once-Weekly GLP-1 Patch Into Phase I - Femtech Insider
First patient dosed in Onchilles’ Phase I/II trial of N17350 - Clinical Trials Arena
Moonlight begins SURVEYOR Phase I trial for peanut allergy - Clinical Trials Arena
Immutep’s IMP761 LAG-3 Agonist Meets Safety Goals in Phase I Trial - The Clinical Trial Vanguard
First patient dosed in phase I/II trial of complement-targeting gene therapy for geographic atrophy - Ophthalmology Times
EHA 2026 | What are the key findings from the phase I ANTLER trial in R/R B-cell NHL? - Lymphoma Hub
uniQure reports preliminary AMT-260 Phase I/IIa low-dose results; 3 of 6 patients show 79–100% seizure reduction - TradingView
C20-2024-018 - Downtown Density Bonus Update - Phase I - Speak Up Austin
Orion Pharma reports Phase I data from TEADES trial for solid tumours - Clinical Trials Arena
MUHC launches world’s first radioligand therapy trial for HER2-positive cancers - McGill University Health Centre
EHA 2026 | What are the most recent findings from the phase I NX-5948-301 trial evaluating bexobrutideg in CLL? - Lymphoma Hub
Insilico and TaiGen achieve milestone in collaboration: Out-licensed CKD anemia candidate ISM4808 completes first human enrollment and dosing in Phase I clinical trial - Insilico Medicine
Jade reports interim Phase I results of JADE101 for IgAN - Clinical Trials Arena
What Operation TrialBlazer means for CDMOs and CMC strategy - Manufacturing Chemist
SpyGlass Pharma reports positive 12-month phase I/II results for BIM-IOL System in glaucoma and ocular hypertension - Ophthalmology Times
Novartis delpacibart braxlosiran (del-brax) Phase I/II - GlobeNewswire
Design Therapeutics reports Phase I/II RESTORE-FA trial outcomes - Clinical Trials Arena
Downieville Phase I: Fuels Reduction Handwork Implementation - National Forest Foundation
Kalohexis doses first patients in 710GO Phase I trial for obesity - Clinical Trials Arena
RBI Grade B Result 2026 Out: Phase 1 Scores Released, Phase 2 Exam on July 25 - NDTV
Proposed Plan of Remedial Action for the Roads Phase I Operable Unit 1 (OU-1) Site (DE-1732) - Delaware.gov
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy - Yahoo Finance
TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG - Yahoo Finance
Artificial intelligence designed drugs Hit 90% Phase I success rate in trials - 2 Minute Medicine
AAN 2026: Phase I/II success for rese-cel in gMG signals potential amid competition - Clinical Trials Arena
War Department Announces Vendors Invited to Compete in Phase I of the Drone Dominance Program - U.S. Department of War (.gov)
Rocio Bauer: Army Completes Digital Engineering Ecosystem Phase I - ExecutiveGov
specific siRNA in pancreatic cancer: a phase I study with immunological correlates - Nature
REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202 - PR Newswire
HAYA Therapeutics doses first cohort in Phase I HTX-001 trial - Clinical Trials Arena
Hemispherian begins Phase I/IIa trial of GLIX1 for GBM - Clinical Trials Arena
Over-volunteering in Phase I clinical trials: data from a healthy volunteers’ registry in Japan - European Society of Medicine
Indonesia, Switzerland and UNDP Launch Next Phase of Sustainable Landscape Transformation in Indonesia - UNDP
First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial - Clinical Trials Arena
Vir Biotechnology doses first patient in Phase I VIR-5500 trial - Clinical Trials Arena
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors - The New England Journal of Medicine
North Florida Baseball Reveals Harmon Stadium Phase I Renovations - University of North Florida Athletics
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer - Nature
ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406 - PR Newswire
Does a Negligent Phase I Result in Loss of the CERCLA Innocent Purchaser Defense? - Law.com
Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO - Ophthalmology Times
iOnctura initiates Phase I/II trial in patients with myelofibrosis ahead of new non-clinical data at ASH - PR Newswire
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody - PR Newswire
Tenvie doses first subject in Phase I TNV108 trial for peripheral neuropathies - Clinical Trials Arena
Phase I NSCLC trials shrink and cluster in major U.S. cities - News-Medical
Comparative pharmacoinformatic and quantum descriptor insights from BFM/GBTLI guidelines to phase I/II compounds for acute lymphoblastic leukemia (ALL) | Scientific Reports - Nature
Moonlight Therapeutics Initiates Phase I Clinical Trial (SURVEYOR) of MOON101 for Peanut Allergy - Business Wire
ESCMID Global 2026: TherVacB Phase I data supports continued development - Clinical Trials Arena
Auburn Phase I Drought Watch - City of Auburn (AL) (.gov)
GlycoNex secures Japan’s PMDA approval for GNX1021 Phase I trial - Clinical Trials Arena
Magnolia Avenue - Phase I Improvements - City of Orlando (.gov)
GSK announces positive outcomes from Phase I BEHOLD-1 trial of Mo-Rez - Clinical Trials Arena
Phase I study for human monoclonal antibody for Lyme disease demonstrates safety, tolerability, pharmacokinetics - UMass Chan Medical School
SK bioscience begins international Phase I/II trial for GBP511 vaccine - Clinical Trials Arena
Phase I Trial of Neoantigen Vaccine Shows 100% DFS Rate in HNSCC - Targeted Oncology
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data - Applied Clinical Trials Online
Arrowhead begins dosing in Phase I/IIa trial for hyperlipidaemia - Clinical Trials Arena
AvenCell Therapeutics Announces First Patient Dosed in Phase I QUADvance Study with AVC-203, a Novel Allogeneic CD19/CD20 Dual-Targeting CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-Cell Malignancies - PR Newswire
ATS 2026: promising Phase I interim results with KB407 in cystic fibrosis - Clinical Trials Arena
Lysoway Therapeutics Announces Phase I Dosing of LW-1017, the First TRPML1 Agonist to Enter Clinical Development - Business Wire
MIRA Pharmaceuticals completes dosing in Ketamir-2 Phase I trial - Clinical Trials Arena
Argo Biopharma begins dosing for Phase I BW-50218 trial - Clinical Trials Arena
Vico Therapeutics initiates patient dosing for VO659 Phase I/IIa trial - Clinical Trials Arena
Archeus doses first patient in phase I RPT trial - AuntMinnie
FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss - Ophthalmology Times
Phase I Trial of New Cell Therapy Shows Promise for Mesothelioma - Mesothelioma.net
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026 - GlobeNewswire
Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants - ASM Journals
Program Update - Phase I Transition - Florida Department of Environmental Protection (.gov)
Argo Biopharma Announces First Subject Dosed in Phase I Study of siRNA Therapeutic BW-50218 - PR Newswire
New Phase I/II Trial Using Multimodal PDT for Advanced, Recurrent Colorectal Cancer - Roswell Park Comprehensive Cancer Center
HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours - Clinical Trials Arena
SBICAPS appointed to study Hyderabad Metro Phase-I valuation, Phase-II expansion - The News Minute
Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma - Neurology® Journals
Wave’s stock crashes 50% on Phase I obesity data - Clinical Trials Arena
PLL Therapeutics reports positive phase I/II data for gut-targeting ALS therapy - European Biotechnology Magazine
Phase I data from the DAREON-7 trial evaluating obrixtamig, a DLL3/CD3 T-cell engager, in combination with platinum-based chemotherapy plus etoposide as first-line therapy for DLL3-positive neuroendocrine carcinomas - OncLive
VectorY doses first participant in Phase I/II PIONEER-ALS trial - Clinical Trials Arena
PHL Completes Phase I of Taxiway S Rehab Project - Philadelphia International Airport
Foreign Language Equivalents
Foreign Language Equivalents of 'phase i'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
phase ii,   phas ei,   phas i,   pahse i,   phasei,   pjase i,   pgase i,   phasee i,   hase i,   phasw i,   phse i,   phasse i,   phasr i,   phaae i,   phaase i,   phsse i,   phae i,   phade i,   phase o,   pase i,   phase ,   phhase i,   pphase i,   phase i,   ohase i,   phsae i,   phase u,   [hase i,   phaes i,   phasei ,   hpase i
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z